UBS has increased its price target for Zillow Group (NASDAQ:ZG) shares to $98 from the previous target of $90, while keeping a Buy rating on the stock. Currently trading at $77.98, Zillow has shown impressive momentum with a nearly 60% gain over the past six months.

UBS analyst Patrick Rafaisz maintained a Buy rating on Lonza Group Ltd (LONN – Research Report) today and set a price target of

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis Griffin, according to the announcement. The team joined LPL's core platform, affiliating with the firm in a 1099 relationship and using a shared Form ADV.

FnPS unlocks the potential for truly digital business models within and between institutions and helps accelerate transformation towards digital capital markets. Request the whitepaper Not a product of UBS research and does not constitute a financial ...

RBC Capital analyst Arun Viswanathan maintained a Hold rating on Pactiv Evergreen (PTVE – Research Report) yesterday and set a price target of

Last week's sell-off in Inchcape's shares was overdone, according to analysts at Citi, which retained a 'buy' rating on the stock.

BMO Capital Markets has recently reduced Exelixis Inc (EXEL) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 17, 2024, BofA Securities had reduced the stock from a Buy to Neutral,

UBS updated its outlook for U.S. midcap banks, revising earnings estimates and highlighting key performers in the sector. Analysts noted that since the start of bank earnings announcements last week,

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $75.0 to $135.0 for Abbott Laboratories over the last 3 months.

On Thursday, RBC Capital Markets adjusted its outlook on shares ... driven by expected higher revenues and share buybacks. UBS increased their price target for JPMorgan shares to $287 from the ...

We recently compiled a list of the 10 Best European Bank Stocks to Buy According to Analysts. In this article, we are going to take a look at where UBS Group AG (NYSE:UBS) stands against the other

Piper Sandler adjusted its price target for Regeneron Pharmaceuticals (NASDAQ:REGN) shares, reducing it from the previous $1,195.00 to $1,013.00. Despite this change, the firm maintained its Overweight rating on the biotech company's stock.